THE IMMUNE SELF-ASSOCIATED STORAGE ORGANELLE (SASO)
免疫自联存储细胞器 (SASO)
基本信息
- 批准号:10639168
- 负责人:
- 金额:$ 60.68万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-01-20 至 2027-12-31
- 项目状态:未结题
- 来源:
- 关键词:Antigen PresentationAntigen-Presenting CellsAntigensAreaAutoimmunityBiological ModelsBiological ProcessBiologyCRISPR screenCell DeathCellsCompetenceComplementCytometryCytosolDataDendritic CellsDiagnosticEducational process of instructingElectron MicroscopyEngineeringFlow CytometryGenerationsGenesGenetic ScreeningGoalsGrantHealthHomeostasisImageImmuneImmune systemImmunoassayImmunologicsImmunotherapeutic agentIn VitroInfectionIngestionInjuryIntentionKnock-outKnowledgeLeadLicensingLifeLightMacrophageMalignant NeoplasmsMass Spectrum AnalysisMembraneMemoryMethodsMicroscopyMolecularMyelogenousMyeloid CellsNational Institute of Allergy and Infectious DiseaseOrganellesOrganismPhagocytosisPopulationProcessProteinsProteomicsReagentResearchResearch PersonnelRestSamplingSelf PerceptionSelf ToleranceSpecific qualifier valueSpeedSurfaceSynapsesSystems BiologyT cell differentiationT-LymphocyteTechnologyTestingTimeTumor AntigensTumor ImmunityTumor-associated macrophagesVesicleWorkanalytical methoddesigndraining lymph nodeexhaustiongenetic testinghigh dimensionalityhuman diseaseimprovedin vivoinnovationinterestlymph nodesmigrationmutantnext generationnovelprogramstumor
项目摘要
PROJECT SUMMARY
This study investigates how the body maintains a memory of ‘Self’. When facing foreign organisms and cancer,
this self-knowledge is thought to be critical, serving to educate the immune system to limit autoimmunity and
conversely license reactivity to things that are ‘Foreign’. The core of the study focuses on a newly-discovered
organelle, found within macrophages and some dendritic cells which we call the Self-Associated Storage
Organelle or SASO for short. We believe that the SASO is critical to ‘hold’ our self-identity and subsequently
educate the rest of our immune system and it appears to come from a stealthy and subtle form of ‘cell
nibbling’.Our proposal is unique in applying cutting technologies—lattice-light sheet imaging, vesicle flow, Mass-
spectrometry and Electron Microscopy—together with conventional cellular immunoassay methods and genetic
screens, to understand how this newly described component of the immune system works as well as how we
can harness it to improve health. The resultant discoveries will be formative for designing new ways to boost
anti-tumor immunity, to minimize autoimmunity and to broadly regulate which components of our bodies are seen
as ‘Self’.
项目摘要
这项研究探讨了身体如何保持对“自我”的记忆。当面对外来生物和癌症时,
这种自我认识被认为是至关重要的,用于训练免疫系统以限制自身免疫,
相反,许可证反应的东西是'外国'。这项研究的核心集中在一个新发现的
细胞器,在巨噬细胞和一些树突细胞中发现,我们称之为自相关存储
细胞器或简称SASO。我们相信,SASO对“保持”我们的自我认同至关重要,
教育我们的免疫系统的其余部分,它似乎来自一个秘密和微妙的形式'细胞
我们的建议是独特的应用切割技术-晶格光片成像,囊泡流,质量,
光谱法和电子显微镜-与传统的细胞免疫测定方法和遗传
屏幕,以了解这个新描述的免疫系统的组成部分是如何工作的,以及我们如何
可以利用它来改善健康。由此产生的发现将有助于设计新的方法来提高
抗肿瘤免疫,最大限度地减少自身免疫,并广泛调节我们身体的哪些组成部分被视为
作为“自我”。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MATTHEW F KRUMMEL其他文献
MATTHEW F KRUMMEL的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MATTHEW F KRUMMEL', 18)}}的其他基金
The Tumor Microenvironment Niche of Type I conventional Dendritic Cells
I型常规树突状细胞的肿瘤微环境生态位
- 批准号:
10660263 - 财政年份:2023
- 资助金额:
$ 60.68万 - 项目类别:
Anti-Tumor Mechanisms of Intratumoral Stimulatory Dendritic Cells
瘤内刺激树突状细胞的抗肿瘤机制
- 批准号:
9311801 - 财政年份:2017
- 资助金额:
$ 60.68万 - 项目类别:
Manipulating collectivity and Niches for Developing CD8 Immunity
操纵集体和利基来发展 CD8 免疫力
- 批准号:
9282416 - 财政年份:2015
- 资助金额:
$ 60.68万 - 项目类别:
Living Tumor Biopsies to Interrogate Immune Function and Response to Therapy
活体肿瘤活检以询问免疫功能和对治疗的反应
- 批准号:
9135274 - 财政年份:2015
- 资助金额:
$ 60.68万 - 项目类别:
Manipulating collectivity and Niches for Developing CD8 Immunity
操纵集体和利基来发展 CD8 免疫力
- 批准号:
8964056 - 财政年份:2015
- 资助金额:
$ 60.68万 - 项目类别:
CUTTING EDGE LINEAGE TRACKING OF TUMOR-EDUCATED IMMUNE CELLS
肿瘤免疫细胞的尖端谱系追踪
- 批准号:
8990830 - 财政年份:2015
- 资助金额:
$ 60.68万 - 项目类别:
Defining the First Hours of Lung metastasis using Intravital Live-Imaging
使用活体实时成像定义肺转移的最初几个小时
- 批准号:
8464682 - 财政年份:2012
- 资助金额:
$ 60.68万 - 项目类别:
Defining the First Hours of Lung metastasis using Intravital Live-Imaging
使用活体实时成像定义肺转移的最初几个小时
- 批准号:
8281837 - 财政年份:2012
- 资助金额:
$ 60.68万 - 项目类别:
Multiphoton Instrumentation for Translational Assays from Human Tissue Biopsies
用于人体组织活检转化分析的多光子仪器
- 批准号:
7838245 - 财政年份:2011
- 资助金额:
$ 60.68万 - 项目类别:
Imaging T Cell Airway Responses during Inflammation
炎症期间 T 细胞气道反应的成像
- 批准号:
8239549 - 财政年份:2011
- 资助金额:
$ 60.68万 - 项目类别:
相似海外基金
Tri-Signal Artificial Antigen Presenting Cells for Cancer Immunotherapy
用于癌症免疫治疗的三信号人工抗原呈递细胞
- 批准号:
10751133 - 财政年份:2023
- 资助金额:
$ 60.68万 - 项目类别:
Microfluidic Precision Engineered Artificial Antigen Presenting Cells for Cancer Immunotherapy
用于癌症免疫治疗的微流控精密工程人工抗原呈递细胞
- 批准号:
10696138 - 财政年份:2022
- 资助金额:
$ 60.68万 - 项目类别:
The role of microglia as antigen presenting cells in Globoid Cell Leukodystrophy
小胶质细胞作为抗原呈递细胞在球状细胞脑白质营养不良中的作用
- 批准号:
10663066 - 财政年份:2022
- 资助金额:
$ 60.68万 - 项目类别:
The role of microglia as antigen presenting cells in Globoid Cell Leukodystrophy
小胶质细胞作为抗原呈递细胞在球状细胞脑白质营养不良中的作用
- 批准号:
10537159 - 财政年份:2022
- 资助金额:
$ 60.68万 - 项目类别:
Analysis of the function of antigen-presenting cells present in the stroma of colorectal cancer and the intracellular microbiome
结直肠癌基质中抗原呈递细胞和细胞内微生物组的功能分析
- 批准号:
21K08723 - 财政年份:2021
- 资助金额:
$ 60.68万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Class II artificial antigen presenting cells for cancer immunotherapy
用于癌症免疫治疗的 II 类人工抗原呈递细胞
- 批准号:
10156950 - 财政年份:2021
- 资助金额:
$ 60.68万 - 项目类别:
The role of CX3CR1+ antigen presenting cells in T cell selection and central tolerance"
CX3CR1抗原呈递细胞在T细胞选择和中枢耐受中的作用"
- 批准号:
10631854 - 财政年份:2021
- 资助金额:
$ 60.68万 - 项目类别:
Reprogramming Cancer Cells into Antigen Presenting Cells: Cancer Vaccination with mRNA Enabled by Charge-Altering Releasable Transporters
将癌细胞重编程为抗原呈递细胞:通过改变电荷的可释放转运蛋白实现 mRNA 的癌症疫苗接种
- 批准号:
10153927 - 财政年份:2021
- 资助金额:
$ 60.68万 - 项目类别:
Class II artificial antigen presenting cells for cancer immunotherapy
用于癌症免疫治疗的 II 类人工抗原呈递细胞
- 批准号:
10331830 - 财政年份:2021
- 资助金额:
$ 60.68万 - 项目类别:
Analysis on detrimental interplay between pathogenic helper T cells, inflammatory antigen-presenting cells and disease-associated microglia in chronic pathogenesis of multiple sclerosis
多发性硬化症慢性发病机制中致病性辅助 T 细胞、炎症抗原呈递细胞和疾病相关小胶质细胞之间的有害相互作用分析
- 批准号:
20K16294 - 财政年份:2020
- 资助金额:
$ 60.68万 - 项目类别:
Grant-in-Aid for Early-Career Scientists